Nutcracker Therapeutics Overview
- Year Founded
-
2017
- Status
-
Out of Business
- Employees
-
102
- Latest Deal Type
-
Out of Business
Nutcracker Therapeutics General Information
Description
Developer of a biotech platform designed for creating mRNA-based therapeutic drug products. The company's platform utilizes proprietary hardware and software combined with innovations in mRNA biochemistry and nanoparticle delivery to produce optimized therapies on biochips, enabling medical professionals to discover, develop, and manufacture complex mRNA therapies and vaccines and improve human health.
Contact Information
Website
www.nutcrackerx.comCorporate Office
- 5858 Horton Street
- Suite 540
- Emeryville, CA 94608
- United States
Corporate Office
- 5858 Horton Street
- Suite 540
- Emeryville, CA 94608
- United States
Nutcracker Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 21-Nov-2025 | Completed | Out of Business | |||
| 4. Later Stage VC (Series C) | 14-Mar-2022 | Completed | Pre-Clinical Trials | |||
| 3. Early Stage VC (Series B) | 23-Sep-2020 | Completed | Startup | |||
| 2. Seed Round | 20-Mar-2019 | $10M | $14M | Completed | Startup | |
| 1. Seed Round | 17-May-2018 | $4M | $4M | Completed | Startup |
Nutcracker Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 7,039,610 | $0.000100 | 6% | $1.75 | $1.75 | 1x | $1.75 | 7.83% |
| Seed | 22,857,143 | $0.000100 | 6% | $0.17 | $0.17 | 1x | $0.17 | 25.41% |
Nutcracker Therapeutics Comparisons
Industry
Financing
Details
Nutcracker Therapeutics Competitors (3)
One of Nutcracker Therapeutics’s 3 competitors is etherna, a Formerly VC-backed company based in Niel, Belgium.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| etherna | Formerly VC-backed | Niel, Belgium | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| BioNTech | Formerly VC-backed | Mainz, Germany |
Nutcracker Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Nutcracker Therapeutics Patents
Nutcracker Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026039327-A1 | Microfluidic apparatus with asymmetrical chambers | Pending | 12-Aug-2024 | ||
| WO-2025193642-A1 | Rna purification methods | Pending | 12-Mar-2024 | ||
| WO-2025171198-A1 | Apparatus and method for treating rna with beads | Pending | 09-Feb-2024 | ||
| WO-2025155751-A1 | Improved method for isolating and characterizing proteins | Pending | 17-Jan-2024 | ||
| WO-2025137576-A1 | Multiple specific antibodies targeting cd19, cd20, and/or cd47 | Inactive | 22-Dec-2023 | C07K16/2803 |
Nutcracker Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Nutcracker Therapeutics FAQs
-
When was Nutcracker Therapeutics founded?
Nutcracker Therapeutics was founded in 2017.
-
Where is Nutcracker Therapeutics headquartered?
Nutcracker Therapeutics is headquartered in Emeryville, CA.
-
What is the size of Nutcracker Therapeutics?
Nutcracker Therapeutics has 102 total employees.
-
What industry is Nutcracker Therapeutics in?
Nutcracker Therapeutics’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Nutcracker Therapeutics a private or public company?
Nutcracker Therapeutics is a Private company.
-
What is Nutcracker Therapeutics’s current revenue?
The current revenue for Nutcracker Therapeutics is .
-
How much funding has Nutcracker Therapeutics raised over time?
Nutcracker Therapeutics has raised $241M.
-
Who are Nutcracker Therapeutics’s competitors?
etherna, Inovio Pharmaceuticals, and BioNTech are competitors of Nutcracker Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
